Neoplasms Clinical Trials
2 recruiting trials for Neoplasms. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT04949282
Spanish Series of Patients Treated With the Radionuclide Lutetium177
This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine...
Sponsor: Sociedad Española de Medicina Nuclear e Imagen MolecularEnrolling: 500020 locations
RECRUITINGPhase 1 / Phase 2NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants...
This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administered intravenously in...
Sponsor: Marengo Therapeutics, Inc.Enrolling: 36520 locations